Status:
UNKNOWN
Neuromodulation in MS Using Translingual Stimulation
Lead Sponsor:
University of Saskatchewan
Collaborating Sponsors:
Memorial University of Newfoundland
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The overarching aim of this study is to examine if there is additional benefit to adding trans-lingual electrical stimulation to physiotherapy aimed at improving walking and balance in people with mul...
Detailed Description
This is a two arm, participant-blinded, interventionist blinded, and research assessor-blinded RCT Participants with walking problems due to MS (Patient Determined Disease Steps PDDS 3-6) will be rand...
Eligibility Criteria
Inclusion
- confirmed diagnosis of multiple sclerosis
- gait deficit due to MS but still able to walk (EDSS less than 6.5, PDDS 3-6)
- older than 18 and less than 70 years of age
- agree to the study time commitment.
Exclusion
- currently attending physical rehabilitation for walking and/or balance training,
- currently already functional community ambulators (gait speed\>120cm/s)
- contra-indications to the use of translingual electrical stimulation (active or suspected malignant tumor; recent bleeding or open wounds in mouth; women who are pregnant, or sensitivity to nickel, gold or copper)
Key Trial Info
Start Date :
July 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT05275049
Start Date
July 5 2021
End Date
December 1 2022
Last Update
March 11 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial University of Newfoundland
St. John's, Newfoundland and Labrador, Canada, A1A 1E5
2
University of Saskatchewan
Saskatoon, Saskatchewan, Canada, S7N 2Z4